Klingman & Associates, LLC - TONIX PHARMACEUTICALS HLDG C ownership

Quarter-by-quarter ownership
Klingman & Associates, LLC ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q4 2016$5,000
-28.6%
10,0000.0%0.00%0.0%
Q3 2016$7,000
-65.0%
10,0000.0%0.00%
-66.7%
Q2 2016$20,00010,0000.01%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q3 2023
NameSharesValueWeighting ↓
FNY Managed Accounts LLC 75,000$35,258,0000.24%
KINGDON CAPITAL MANAGEMENT, L.L.C. 696,455$327,0000.02%
Klingman & Associates, LLC 10,000$5,0000.00%
BLUESTEIN R H & CO LLC 76,500$36,0000.00%
OPPENHEIMER & CO INC 73,500$34,0000.00%
Renaissance Technologies 774,603$364,0000.00%
Walleye Trading LLC 6$00.00%
Bank of New York Mellon Corp 16,660$8,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11,071$5,0000.00%
SIMPLEX TRADING, LLC 200$00.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders